Skip to content
healthcare.dev
Get a free key

Mucus Relief

NDC 55910-739, Guaifenesin, tablet, from Dolgencorp, Inc. (DOLLAR GENERAL & REXALL).

Product NDC
55910-739
Status
Listed
Labeler
Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)
Dosage form
TABLET
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA207342
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/55910-739 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • GUAIFENESIN600 mg/1

Pharmacologic classes

Decreased Respiratory Secretion Viscosity [PE]; Expectorant [EPC]; Increased Respiratory Secretions [PE]

Package NDCNDC-11Package
55910-739-205591007392020 BLISTER PACK in 1 CARTON (55910-739-20) / 1 TABLET in 1 BLISTER PACK

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 55910-739 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/55910-739 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 55910-739. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.